Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,521,414
+$94,859 QoQ
Shares Held
9,928
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,151
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEDDOCK CAPITAL ADVISORS, LLC holds $14,670,442 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,107 | $6,125,489 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,928 | $2,521,414 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
18,257 | $2,306,589 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,129 | $1,173,076 | |
| 5 | PFE |
Pfizer Inc
|
34,780 | $837,502 | |
| 6 | ABBV |
AbbVie Inc.
|
2,850 | $717,174 | |
| 7 | NVS |
Novartis AG
|
2,632 | $412,487 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,264 | $303,311 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,521,414 | 9,928 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,426,555 | 9,927 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,054,392 | 9,927 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,836,028 | 9,902 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,512,530 | 9,902 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,636,177 | 9,866 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,421,759 | 9,831 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,610,066 | 9,935 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,433,537 | 9,808 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,534,284 | 9,699 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,493,732 | 9,530 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,494,732 | 9,597 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,574,757 | 9,514 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,478,700 | 9,540 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,575,188 | 8,917 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,408,980 | 8,625 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,503,687 | 8,471 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,474,199 | 8,318 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $900,512 | 5,264 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $872,746 | 5,404 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $886,960 | 5,384 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $909,184 | 5,532 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $919,413 | 5,842 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $877,200 | 5,892 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $828,591 | 5,892 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $772,617 | 5,892 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||